Man Group’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Man Group’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-120,000	Closed	-$7.46M	–	2325
2023 Q4	$7.46M	Buy	+120,000	New	+$2.98M	0.02%	787

Man Group's RYZB Position: Q1 2024 in Review

Man Group sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 120,000 shares — an estimated $7.46M sold.

Man Group first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $7.46M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Man Group reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Man Group sold 120,000 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $7.46M.
Man Group first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Man Group's RayzeBio, Inc. Common Stock position peaked at $7.46M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Man Group's 13F filing for Q1 2024, filed 15 May 2024.